08:00 , Mar 10, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Cancer Not applicable A study in mice and in cell culture identified duocarmycin-based prodrugs that could help treat hypoxia-associated cancers. In a panel of...
07:00 , Apr 11, 2005 |  BC Week In Review  |  Company News

Phylogica management update

Phylogica Ltd. (ASX:PYC), Perth, Australia   Business: Neurology, Cancer, Inflammation   Hired: Greg Pullen as COO, formerly general manager of technology and development at Auckland UniServices Ltd.  ...
08:00 , Dec 15, 1997 |  BioCentury  |  Emerging Company Profile

NeuronZ Ltd.

NeuronZ Ltd. Auckland, New Zealand Technology: Neuronal rescue Disease focus: Acute neurological injuries and neurodegenerative diseases Clinical status: Preclinical Founded: 1996 by Auckland UniServices Ltd. Corporate partners: Genentech Inc. University collaborators: University of Auckland, Hammersmith...
08:00 , Dec 15, 1997 |  BioCentury  |  Emerging Company Profile

NeuronZ: New path to neuronal rescue

Peter Gluckman, a pediatrician and endocrinologist who is now dean of medicine at the University of Auckland, began studying neonatal asphyxia in the late 1980s. He found that two to three days after such an...